{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:58:34Z","timestamp":1781632714781,"version":"3.54.5"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202201ZYTS439"],"award-info":[{"award-number":["YDZJ202201ZYTS439"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["135131002"],"award-info":[{"award-number":["135131002"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Jilin Province Development and Reform Commission","award":["2022C044-3"],"award-info":[{"award-number":["2022C044-3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major contributor to chronic liver disease worldwide, yet the molecular mechanisms driving its pathogenesis remain incompletely defined. Although dysregulated hepatic lipogenesis is a well-established driver of MASLD progression, the role of testes-specific protease 50 (TSP50)\u2014an enzyme with demonstrated oncogenic functions in multiple cancers\u2014in hepatic lipid metabolism and its potential involvement in the development of MASLD remains unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study utilized the STelic Animal Model (STAM) along with high-fat\/high-cholesterol plus fructose (HFF) and methionine-choline deficient (HFMCD) dietary models to evaluate the functional role of TSP50 in MASLD progression. Hepatocyte-specific knockout and AAV-mediated TSP50 reconstitution were performed to assess cell-autonomous effects. Mechanistic insights were gained through biochemical analyses of lipid metabolism pathways and protein interaction studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TSP50 deficiency markedly accelerated MASLD progression across all experimental models, promoting hepatic steatosis, inflammation and fibrosis while increasing susceptibility to hepatocellular carcinoma (HCC). Conversely, TSP50 supplementation exerted protective effects against MASLD development. Furthermore, we identified a novel regulatory mechanism whereby TSP50 directly interacts with and degrades stearoyl-CoA desaturase 1 (SCD1) through its catalytic hydrolase activity, thereby suppressing de novo lipogenesis. The inhibitor of SCD1 rescued hepatic TSP50 knockout induced lipid accumulation and liver injury during MASLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study reveals the role of TSP50 in hepatic lipid metabolism, identifying it as a novel regulator of hepatic de novo lipogenesis that exerts protective effects against MASLD through catalytic degradation of SCD1. These findings not only advance our understanding of MASLD pathogenesis but also offer novel insights for developing therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s11658-026-00859-2","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T18:04:17Z","timestamp":1769969057000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["TSP50 attenuates metabolic dysfunction-associated steatotic liver disease via SCD1 degradation-mediated suppression of hepatocyte lipogenesis"],"prefix":"10.1186","volume":"31","author":[{"given":"Jiujia","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxue","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenbo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luguo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guannan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongli","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,1]]},"reference":[{"issue":"8","key":"859_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","volume":"20","author":"JM Llovet","year":"2023","unstructured":"Llovet JM, Willoughby CE, Singal AG, Greten TF, Heikenw\u00e4lder M, El-Serag HB, et al. Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment. Nat Rev Gastroenterol Hepatol. 2023;20(8):487\u2013503.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"859_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.02.033","author":"GR Steinberg","year":"2025","unstructured":"Steinberg GR, Valvano CM, De Nardo W, Watt MJ. Integrative metabolism in MASLD and MASH: pathophysiology and emerging mechanisms. J Hepatol. 2025. https:\/\/doi.org\/10.1016\/j.jhep.2025.02.033.","journal-title":"J Hepatol"},{"issue":"15","key":"859_CR3","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380(15):1450\u201362.","journal-title":"N Engl J Med"},{"issue":"1","key":"859_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"859_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s40265-024-02045-0","volume":"84","author":"SJ Keam","year":"2024","unstructured":"Keam SJ. Resmetirom: first approval. Drugs. 2024;84(6):729\u201335.","journal-title":"Drugs"},{"issue":"10","key":"859_CR6","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S2468-1253(24)00193-6","volume":"9","author":"H Hagstr\u00f6m","year":"2024","unstructured":"Hagstr\u00f6m H, Shang Y, Hegmar H, Nasr P. Natural history and progression of metabolic dysfunction-associated steatotic liver disease. Lancet Gastroenterol Hepatol. 2024;9(10):944\u201356.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"859_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.603926","volume":"11","author":"C Peng","year":"2020","unstructured":"Peng C, Stewart AG, Woodman OL, Ritchie RH, Qin CX. Non-alcoholic steatohepatitis: a review of its mechanism, models and medical treatments. Front Pharmacol. 2020;11:603926.","journal-title":"Front Pharmacol"},{"issue":"10290","key":"859_CR8","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212\u201324.","journal-title":"Lancet"},{"issue":"10","key":"859_CR9","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184(10):2537\u201364.","journal-title":"Cell"},{"issue":"3","key":"859_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41573-024-01084-2","volume":"24","author":"A Do","year":"2025","unstructured":"Do A, Zahrawi F, Mehal WZ. Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH). Nat Rev Drug Discov. 2025;24(3):171\u201389.","journal-title":"Nat Rev Drug Discov"},{"issue":"10464","key":"859_CR11","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","volume":"404","author":"M Israelsen","year":"2024","unstructured":"Israelsen M, Francque S, Tsochatzis EA, Krag A. Steatotic liver disease. Lancet. 2024;404(10464):1761\u201378.","journal-title":"Lancet"},{"issue":"1","key":"859_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1146\/annurev-physiol-022724-105515","volume":"87","author":"M Dukewich","year":"2025","unstructured":"Dukewich M, Yuan L, Terrault NA. At the crossroads of health and disease: consequences of fat in the liver. Annu Rev Physiol. 2025;87(1):325\u201352.","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"859_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/liv.70006","volume":"45","author":"F Dahboul","year":"2025","unstructured":"Dahboul F, Sun J, Buchard B, Abeywickrama-Samarakoon N, Pujos-Guillot E, Durand S, et al. Simultaneous activation of beta-oxidation and de novo lipogenesis in MASLD-HCC: a new paradigm. Liver Int. 2025;45(2):e70006.","journal-title":"Liver Int"},{"issue":"8","key":"859_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/ddr.20139","volume":"67","author":"P Dobrzyn","year":"2006","unstructured":"Dobrzyn P, Dobrzyn A. Stearoyl-CoA desaturase: a new therapeutic target of liver steatosis. Drug Dev Res. 2006;67(8):643\u201350.","journal-title":"Drug Dev Res"},{"issue":"6","key":"859_CR15","doi-asserted-by":"publisher","first-page":"E710","DOI":"10.1152\/ajpendo.00151.2017","volume":"313","author":"MA Lounis","year":"2017","unstructured":"Lounis MA, Bergeron KF, Burhans MS, Ntambi JM, Mounier C. Oleate activates SREBP-1 signaling activity in SCD1-deficient hepatocytes. Am J Physiol Endocrinol Metab. 2017;313(6):E710-e720.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"24","key":"859_CR16","doi-asserted-by":"publisher","first-page":"25164","DOI":"10.1074\/jbc.M402781200","volume":"279","author":"M Miyazaki","year":"2004","unstructured":"Miyazaki M, Dobrzyn A, Man WC, Chu K, Sampath H, Kim HJ, et al. Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and -independent mechanisms. J Biol Chem. 2004;279(24):25164\u201371.","journal-title":"J Biol Chem"},{"key":"859_CR17","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.2741\/2352","volume":"12","author":"HY Xu","year":"2007","unstructured":"Xu HY, Wilcox D, Nguyen P, Voorbach M, Smith H, Brodjian S, et\u00a0al. Hepatic knockdown of stearoyl-COA desaturase 1 via RNA interference in obese mice decreases lipid content and changes fatty acid composition. Front Biosci Landmark. 2007;12:3781\u201394.","journal-title":"Front Biosci Landmark"},{"issue":"3","key":"859_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100237","volume":"3","author":"D Bhattacharya","year":"2021","unstructured":"Bhattacharya D, Basta B, Mato JM, Craig A, Fern\u00e1ndez-Ramos D, Lopitz-Otsoa F, et al. Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis. JHEP Rep. 2021;3(3):100237.","journal-title":"JHEP Rep"},{"issue":"9","key":"859_CR19","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/hep4.1107","volume":"1","author":"M Iruarrizaga-Lejarreta","year":"2017","unstructured":"Iruarrizaga-Lejarreta M, Varela-Rey M, Fern\u00e1ndez-Ramos D, Mart\u00ednez-Arranz I, Delgado TC, Simon J, et\u00a0al. Role of Aramchol in steatohepatitis and fibrosis in mice. Hepatol Commun. 2017;1(9):911\u201327.","journal-title":"Hepatol Commun"},{"issue":"1","key":"859_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12964-023-01297-9","volume":"21","author":"W Wang","year":"2023","unstructured":"Wang W, Kong Y, Wang X, Wang Z, Tang C, Li J, et al. Identification of novel SCD1 inhibitor alleviates nonalcoholic fatty liver disease: critical role of liver-adipose axis. Cell Commun Signal. 2023;21(1):268.","journal-title":"Cell Commun Signal"},{"issue":"10","key":"859_CR21","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/s41591-021-01495-3","volume":"27","author":"V Ratziu","year":"2021","unstructured":"Ratziu V, de Guevara L, Safadi R, Poordad F, Fuster F, Flores-Figueroa J, et\u00a0al. Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial. Nat Med. 2021;27(10):1825\u201335.","journal-title":"Nat Med"},{"issue":"10","key":"859_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/acel.70188","volume":"24","author":"X Li","year":"2025","unstructured":"Li X, Chen Y, Gao Z, Liu X, Song Z, Gao F, et al. TSP50 in neural stem cells regulates aging-related cognitive decline and neuroinflammation by altering the gut microbiota. Aging Cell. 2025;24(10):e70188.","journal-title":"Aging Cell"},{"issue":"1","key":"859_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-025-00737-3","volume":"11","author":"X Li","year":"2025","unstructured":"Li X, Jin R, Wang Z, Niu C, Song Z, Liu X, et al. TSP50 deficiency in neural stem cells aggravates colitis in mice by altering intestinal microbiome. NPJ Biofilms Microbiomes. 2025;11(1):93.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"859_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/genes14122207","author":"H Seo","year":"2023","unstructured":"Seo H, Park JH, Hwang JT, Choi HK, Park SH, Lee J. Epigenetic profiling of type 2 diabetes mellitus: an epigenome-wide association study of DNA methylation in the Korean genome and epidemiology study. Genes. 2023. https:\/\/doi.org\/10.3390\/genes14122207.","journal-title":"Genes"},{"issue":"6","key":"859_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03782-w","volume":"12","author":"F Gao","year":"2021","unstructured":"Gao F, Zhang X, Wang S, Zheng L, Sun Y, Wang G, et al. TSP50 promotes the Warburg effect and hepatocyte proliferation via regulating PKM2 acetylation. Cell Death Dis. 2021;12(6):517.","journal-title":"Cell Death Dis"},{"issue":"4","key":"859_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13015","volume":"54","author":"X Zhang","year":"2021","unstructured":"Zhang X, Gao F, Ai H, Wang S, Song Z, Zheng L, et al. TSP50 promotes hepatocyte proliferation and tumour formation by activating glucose-6-phosphate dehydrogenase (G6PD). Cell Prolif. 2021;54(4):e13015.","journal-title":"Cell Prolif"},{"issue":"4","key":"859_CR27","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.urology.2004.05.012","volume":"64","author":"HP Xu","year":"2004","unstructured":"Xu HP, Yuan L, Shan J, Feng H. Localization and expression of TSP50 protein in human and rodent testes. Urology. 2004;64(4):826\u201332.","journal-title":"Urology"},{"issue":"6","key":"859_CR28","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.3892\/or.2016.4763","volume":"35","author":"WL Qiao","year":"2016","unstructured":"Qiao WL, Hu HY, Shi BW, Zang LJ, Jin W, Lin Q. Lentivirus-mediated knockdown of TSP50 suppresses the growth of non-small cell lung cancer cells via G0\/G1 phase arrest. Oncol Rep. 2016;35(6):3409\u201318.","journal-title":"Oncol Rep"},{"key":"859_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/498246","volume":"2014","author":"F Liu","year":"2014","unstructured":"Liu F, Cao Q, Liu N, Li C, You C, Liu C, et al. Overexpression of testes-specific protease 50 (TSP50) predicts poor prognosis in patients with gastric cancer. Gastroenterol Res Pract. 2014;2014:498246.","journal-title":"Gastroenterol Res Pract"},{"key":"859_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2021.1609990","volume":"27","author":"HMK Youssef","year":"2021","unstructured":"Youssef HMK, Radi DA, Abd El-Azeem MA. Expression of TSP50, SERCA2 and IL-8 in colorectal adenoma and carcinoma: correlation to clinicopathological factors. Pathol Oncol Res. 2021;27:1609990.","journal-title":"Pathol Oncol Res"},{"issue":"10","key":"859_CR31","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1016\/j.cellsig.2014.07.012","volume":"26","author":"ZB Song","year":"2014","unstructured":"Song ZB, Liu B, Li YY, Wu P, Bao YL, Huang YX, et al. The catalytic triad of testes-specific protease 50 (TSP50) is essential for its function in cell proliferation. Cell Signal. 2014;26(10):2266\u201375.","journal-title":"Cell Signal"},{"issue":"11","key":"859_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202305893","volume":"11","author":"J Li","year":"2024","unstructured":"Li J, Niu C, Ai H, Li X, Zhang L, Lang Y, et al. TSP50 attenuates DSS-induced colitis by regulating TGF-\u03b2 signaling mediated maintenance of intestinal mucosal barrier integrity. Adv Sci. 2024;11(11):e2305893.","journal-title":"Adv Sci"},{"issue":"5","key":"859_CR33","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.24272\/j.issn.2095-8137.2023.388","volume":"45","author":"CX Niu","year":"2024","unstructured":"Niu CX, Li JW, Li XL, Zhang LL, Lang Y, Song ZB, et al. PRSS50-mediated inhibition of MKP3\/ERK signaling is crucial for meiotic progression and sperm quality. Zool Res. 2024;45(5):1037\u201347.","journal-title":"Zool Res"},{"issue":"9","key":"859_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2024.100599","volume":"65","author":"P Seubnooch","year":"2024","unstructured":"Seubnooch P, Montani M, Dufour JF, Masoodi M. Spatial lipidomics reveals zone-specific hepatic lipid alteration and remodeling in metabolic dysfunction-associated steatohepatitis. J Lipid Res. 2024;65(9):100599.","journal-title":"J Lipid Res"},{"key":"859_CR35","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf346","author":"S Palomurto","year":"2025","unstructured":"Palomurto S, Virtanen KA, K\u00e4rj\u00e4 V, Schwab U, Kaminska D, K\u00e4kel\u00e4 P, et al. Metabolic dysfunction-associated steatotic liver disease alters fatty acid profiles in the liver and adipose tissue. J Clin Endocrinol Metab. 2025. https:\/\/doi.org\/10.1210\/clinem\/dgaf346.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"859_CR36","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908\u201322.","journal-title":"Nat Med"},{"issue":"18","key":"859_CR37","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci. 2018;75(18):3313\u201327.","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"859_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100346","volume":"3","author":"L Parlati","year":"2021","unstructured":"Parlati L, Regnier M, Guillou H, Postic C. New targets for NAFLD. JHEP Rep Innov Hepatol. 2021;3(6):100346.","journal-title":"JHEP Rep Innov Hepatol"},{"issue":"6","key":"859_CR39","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.cmet.2022.05.004","volume":"34","author":"MR Morrow","year":"2022","unstructured":"Morrow MR, Batchuluun B, Wu J, Ahmadi E, Leroux JM, Mohammadi-Shemirani P, et\u00a0al. Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia. Cell Metab. 2022;34(6):919-936 e918.","journal-title":"Cell Metab"},{"issue":"6","key":"859_CR40","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1002\/hep.30097","volume":"68","author":"L Goedeke","year":"2018","unstructured":"Goedeke L, Bates J, Vatner DF, Perry RJ, Wang T, Ramirez R, et al. Acetyl\u2010CoA carboxylase inhibition reverses NAFLD and hepatic insulin resistance but promotes hypertriglyceridemia in rodents. Hepatology. 2018;68(6):2197\u2013211.","journal-title":"Hepatology"},{"issue":"7628","key":"859_CR41","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nature20117","volume":"539","author":"X Wei","year":"2016","unstructured":"Wei X, Song H, Yin L, Rizzo MG, Sidhu R, Covey DF, et al. Fatty acid synthesis configures the plasma membrane for inflammation in diabetes. Nature. 2016;539(7628):294\u20138.","journal-title":"Nature"},{"issue":"9","key":"859_CR42","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.2337\/db15-0370","volume":"64","author":"J Cordoba-Chacon","year":"2015","unstructured":"Cordoba-Chacon J, Majumdar N, List E, Diaz-Ruiz A, Frank S, Manzano A, et al. Growth hormone inhibits hepatic de novo lipogenesis in adult mice. Diabetes. 2015;64(9):3093\u2013103.","journal-title":"Diabetes"},{"key":"859_CR43","doi-asserted-by":"publisher","DOI":"10.1172\/JCI153724","author":"N Bhat","year":"2022","unstructured":"Bhat N, Narayanan A, Fathzadeh M, Kahn M, Zhang DY, Goedeke L, et al. Dyrk1b promotes hepatic lipogenesis by bypassing canonical insulin signaling and directly activating mTORC2 in mice. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/JCI153724.","journal-title":"J Clin Invest"},{"key":"859_CR44","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000643","author":"C Ke","year":"2023","unstructured":"Ke C, Xiao C, Li J, Wu X, Zhang Y, Chen Y, et al. FMO2 ameliorates nonalcoholic fatty liver disease by suppressing ER-to-Golgi transport of SREBP1. Hepatology. 2023. https:\/\/doi.org\/10.1097\/HEP.0000000000000643.","journal-title":"Hepatology"},{"issue":"3","key":"859_CR45","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1124\/pharmrev.123.001087","volume":"76","author":"M Kokkorakis","year":"2024","unstructured":"Kokkorakis M, Muzurovi\u0107 E, Vol\u010dan\u0161ek \u0160, Chakhtoura M, Hill MA, Mikhailidis DP, et al. Steatotic liver disease: pathophysiology and emerging pharmacotherapies. Pharmacol Rev. 2024;76(3):454\u201399.","journal-title":"Pharmacol Rev"},{"key":"859_CR46","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.164694","author":"KC Nikolaou","year":"2023","unstructured":"Nikolaou KC, Godbersen S, Manoharan M, Wieland S, Heim MH, Stoffel M. Inflammation-induced TRIM21 represses hepatic steatosis by promoting the ubiquitination of lipogenic regulators. JCI Insight. 2023. https:\/\/doi.org\/10.1172\/jci.insight.164694.","journal-title":"JCI Insight"},{"key":"859_CR47","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.85131","author":"MY Wu","year":"2023","unstructured":"Wu MY, Lo TH, Li LP, Sun J, Deng CJ, Chan KY, et al. Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (Adgrf1). Elife. 2023. https:\/\/doi.org\/10.7554\/eLife.85131.","journal-title":"Elife"},{"issue":"17","key":"859_CR48","doi-asserted-by":"publisher","first-page":"11482","DOI":"10.1073\/pnas.132384699","volume":"99","author":"JM Ntambi","year":"2002","unstructured":"Ntambi JM, Miyazaki M, Stoehr JP, Lan H, Kendziorski CM, Yandell BS, et al. Loss of stearoyl\u2013CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci U S A. 2002;99(17):11482\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"859_CR49","doi-asserted-by":"publisher","first-page":"E28","DOI":"10.1152\/ajpendo.90897.2008","volume":"297","author":"CM Paton","year":"2009","unstructured":"Paton CM, Ntambi JM. Biochemical and physiological function of stearoyl-CoA desaturase. Am J Physiol Endocrinol Metab. 2009;297(1):E28-37.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"859_CR50","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1172\/JCI200523962","volume":"115","author":"G Jiang","year":"2005","unstructured":"Jiang G, Li Z, Liu F, Ellsworth K, Dallas-Yang Q, Wu M, et al. Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1. J Clin Invest. 2005;115(4):1030\u20138.","journal-title":"J Clin Invest"},{"issue":"1\u20133","key":"859_CR51","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejphar.2011.09.172","volume":"672","author":"E Kim","year":"2011","unstructured":"Kim E, Lee JH, Ntambi JM, Hyun CK. Inhibition of stearoyl-CoA desaturase1 activates AMPK and exhibits beneficial lipid metabolic effects in vitro. Eur J Pharmacol. 2011;672(1\u20133):38\u201344.","journal-title":"Eur J Pharmacol"},{"key":"859_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2020.581723","volume":"7","author":"B Cao","year":"2020","unstructured":"Cao B, Liu C, Zhang Q, Dong Y. Maternal high-fat diet leads to non-alcoholic fatty liver disease through upregulating hepatic SCD1 expression in neonate rats. Front Nutr. 2020;7:581723.","journal-title":"Front Nutr"},{"issue":"5","key":"859_CR53","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41556-023-01136-6","volume":"25","author":"K Papsdorf","year":"2023","unstructured":"Papsdorf K, Miklas JW, Hosseini A, Cabruja M, Morrow CS, Savini M, et al. Lipid droplets and peroxisomes are co-regulated to drive lifespan extension in response to mono-unsaturated fatty acids. Nat Cell Biol. 2023;25(5):672\u201384.","journal-title":"Nat Cell Biol"},{"issue":"9","key":"859_CR54","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1194\/jlr.M600172-JLR200","volume":"47","author":"WC Man","year":"2006","unstructured":"Man WC, Miyazaki M, Chu K, Ntambi J. Colocalization of SCD1 and DGAT2: implying preference for endogenous monounsaturated fatty acids in triglyceride synthesis. J Lipid Res. 2006;47(9):1928\u201339.","journal-title":"J Lipid Res"},{"issue":"12","key":"859_CR55","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1002\/jcp.31137","volume":"238","author":"Z Tracz-Gaszewska","year":"2023","unstructured":"Tracz-Gaszewska Z, Sowka A, Dobrzyn P. Stearoyl-CoA desaturase 1 inhibition impairs triacylglycerol accumulation and lipid droplet formation in colorectal cancer cells. J Cell Physiol. 2023;238(12):2888\u2013903.","journal-title":"J Cell Physiol"},{"issue":"4","key":"859_CR56","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1074\/jbc.M610158200","volume":"282","author":"H Sampath","year":"2007","unstructured":"Sampath H, Miyazaki M, Dobrzyn A, Ntambi JM. Stearoyl-CoA desaturase-1 mediates the pro-lipogenic effects of dietary saturated fat. J Biol Chem. 2007;282(4):2483\u201393.","journal-title":"J Biol Chem"},{"issue":"1","key":"859_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52339-7","volume":"9","author":"A Aljohani","year":"2019","unstructured":"Aljohani A, Khan MI, Syed DN, Abram B, Lewis S, Neill LO, et al. Hepatic stearoyl-CoA desaturase-1 deficiency-mediated activation of mTORC1- PGC-1\u03b1 axis regulates ER stress during high-carbohydrate feeding. Sci Rep. 2019;9(1):15761.","journal-title":"Sci Rep"},{"issue":"1","key":"859_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2257-y","volume":"11","author":"XY Qin","year":"2020","unstructured":"Qin XY, Su T, Yu W, Kojima S. Lipid desaturation-associated endoplasmic reticulum stress regulates MYCN gene expression in hepatocellular carcinoma cells. Cell Death Dis. 2020;11(1):66.","journal-title":"Cell Death Dis"},{"issue":"3","key":"859_CR59","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1158\/0008-5472.CAN-06-3688","volume":"67","author":"H Xu","year":"2007","unstructured":"Xu H, Shan J, Jurukovski V, Yuan L, Li J, Tian K. TSP50 encodes a testis-specific protease and is negatively regulated by p53. Cancer Res. 2007;67(3):1239\u201345.","journal-title":"Cancer Res"},{"issue":"1","key":"859_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03118-4","volume":"43","author":"F Gao","year":"2024","unstructured":"Gao F, Liu S, Wang J, Wei G, Yu C, Zheng L, et al. TSP50 facilitates breast cancer stem cell-like properties maintenance and epithelial-mesenchymal transition via PI3K p110\u03b1 mediated activation of AKT signaling pathway. J Exp Clin Cancer Res. 2024;43(1):201.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"859_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022203","volume":"6","author":"L Zheng","year":"2011","unstructured":"Zheng L, Xie G, Duan G, Yan X, Li Q. High expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma. PLoS One. 2011;6(7):e22203.","journal-title":"PLoS One"},{"issue":"6","key":"859_CR62","first-page":"8796","volume":"15","author":"WL Qiao","year":"2018","unstructured":"Qiao WL, Shi BW, Han YD, Tang HM, Lin J, Hu HY, et\u00a0al. Testes-specific protease 50 as an independent risk factor for poor prognosis in patients with non-small cell lung cancer. Oncol Lett. 2018;15(6):8796\u2013804.","journal-title":"Oncol Lett"},{"issue":"43","key":"859_CR63","doi-asserted-by":"publisher","first-page":"5948","DOI":"10.1038\/onc.2017.198","volume":"36","author":"ZB Song","year":"2017","unstructured":"Song ZB, Wu P, Ni JS, Liu T, Fan C, Bao YL, et al. Testes-specific protease 50 promotes cell proliferation via inhibiting activin signaling. Oncogene. 2017;36(43):5948\u201357.","journal-title":"Oncogene"},{"issue":"3","key":"859_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.61","volume":"6","author":"ZB Song","year":"2015","unstructured":"Song ZB, Ni JS, Wu P, Bao YL, Liu T, Li M, et\u00a0al. Testes-specific protease 50 promotes cell invasion and metastasis by increasing NF-kappaB-dependent matrix metalloproteinase-9 expression. Cell Death Dis. 2015;6(3):e1703.","journal-title":"Cell Death Dis"},{"issue":"1","key":"859_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4000-y","volume":"18","author":"QH Cao","year":"2018","unstructured":"Cao QH, Liu F, Li CZ, Liu N, Shu M, Lin Y, et al. Testes-specific protease 50 (TSP50) promotes invasion and metastasis by inducing emt in gastric cancer. BMC Cancer. 2018;18(1):94.","journal-title":"BMC Cancer"},{"key":"859_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123560","volume":"370","author":"F Gao","year":"2025","unstructured":"Gao F, Liu S, Sun Y, Yu C, Zheng L, Sun L, et al. Testes-specific protease 50 heightens stem-like properties and improves mitochondrial function in colorectal cancer. Life Sci. 2025;370:123560.","journal-title":"Life Sci"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-026-00859-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00859-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00859-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:29:34Z","timestamp":1781630974000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11658-026-00859-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["859"],"URL":"https:\/\/doi.org\/10.1186\/s11658-026-00859-2","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures performed in this research were reviewed and approved by the Institutional Animal Care and Use Committee of Northeast Normal University (NENU\/IACUC), Jilin, China (approval No. 20210921, dated 14 September 2021) which operates in accordance with the guidelines set forth by ICLAS.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}